Related Experiment Videos
Pediatric cardiac transplantation
J C Mullen1, L L Bailey, A J Razzouk
1Division of Cardiovascular and Thoracic Surgery, University of Alberta, Mackenzie Health Sciences Centre, Edmonton, Canada.
Insights
Pediatric cardiac transplantation offers survival rates comparable to adults, achieving 67% 5-year survival. While infection and rejection are common, the procedure yields excellent functional outcomes for children with severe heart conditions.
Area of Science:
- Cardiology
- Pediatric Surgery
- Immunology
Background:
- Cardiac transplantation is a vital treatment for end-stage heart failure in children.
- Outcomes in pediatric recipients have historically lagged behind adults, necessitating further research.
- Severe congenital and acquired heart diseases present significant challenges in pediatric populations.
Purpose of the Study:
- To evaluate the efficacy and long-term outcomes of cardiac transplantation in pediatric patients.
- To compare pediatric cardiac transplant results with those reported in adult populations.
- To identify the primary long-term complications following pediatric heart transplantation.
Main Methods:
- Retrospective analysis of pediatric cardiac transplant recipients.
- Actuarial survival rate calculation at 5 years.
- Assessment of complication frequencies, focusing on infection and rejection.
Main Results:
- Achieved a 5-year actuarial survival rate of 67 +/- 2% in pediatric cardiac transplant recipients.
- Demonstrated survival rates comparable to those observed in adult cardiac transplantation.
- Identified infection and rejection as the most frequent long-term complications.
Conclusions:
- Pediatric cardiac transplantation is an effective therapeutic option for children with severe heart disease.
- The procedure provides excellent functional results, significantly improving quality of life.
- Ongoing management strategies should prioritize addressing infection and rejection to optimize long-term outcomes.
Abstract:
Cardiac transplantation is an effective therapeutic modality in children, with results comparable to those of adults (5-year actuarial survival, 67 +/- 2%). Infection and rejection are the most frequent long-term complications. Cardiac transplantation provides excellent functional results for many children with severe congenital or acquired heart disease.